Literature DB >> 8118731

The ethical appropriateness of using prognostic scoring systems in clinical management.

J M Luce1, R M Wachter.   

Abstract

The four ethical principles of beneficence, nonmaleficence, autonomy, and social justice provide a framework for making medical decisions, including those that involve the administration of life-sustaining therapies. In recent years, a number of prognostic scoring systems, including the Acute Physiology Assessment and Chronic Health Evaluation (APACHE) system, have been developed to augment clinical judgment in determining which critically ill patients are likely to benefit from such therapies. Although these systems all have limitations, their use in decision making is as ethically appropriate as is the use of clinical judgment, which has its own limitations and has been used for years.

Entities:  

Keywords:  APACHE II; Health Care and Public Health; San Francisco General Hospital

Mesh:

Year:  1994        PMID: 8118731

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  4 in total

Review 1.  The pressure to withhold or withdraw life-sustaining therapy from critically ill patients in the United States.

Authors:  John M Luce; Douglas B White
Journal:  Am J Respir Crit Care Med       Date:  2007-03-22       Impact factor: 21.405

2.  Identifying futility in a paediatric critical care setting: a prospective observational study.

Authors:  A Y Goh; Q Mok
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

3.  [Value of the Hannover Intensive Score (HIS) in internal medicine intensive care].

Authors:  A von Bierbrauer; C Burchardt; H H Müller; P von Wichert
Journal:  Med Klin (Munich)       Date:  1998-09-15

4.  When is it considered reasonable to start a risky and uncomfortable treatment in critically ill patients? A random sample online questionnaire study.

Authors:  M Zink; A Horvath; V Stadlbauer
Journal:  BMC Med Ethics       Date:  2021-11-03       Impact factor: 2.652

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.